Clinical Trials

NCT04534205 | RECRUITING | PHASE2/PHASE3
350 participants

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-21
Start Date:
2021-01-07
Completion:
2029-04-30
Conditions
  • Unresectable Head and Neck Squamous Cell Carcinoma
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
Interventions
  • BIOLOGICAL
No Results Yet
NCT04348747 | RECRUITING | PHASE2
23 participants

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-21
Start Date:
2022-12-19
Completion:
2028-05-15
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Malignant Neoplasm in the Brain
  • Metastatic Triple-Negative Breast Carcinoma
  • Prognostic Stage IV Breast Cancer AJCC v8
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page